BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Ben MD, Polimeni L, Baratta F, Pastori D, Loffredo L, Angelico F. Modern approach to the clinical management of non-alcoholic fatty liver disease. World J Gastroenterol 2014; 20(26): 8341-8350 [PMID: 25024593 DOI: 10.3748/wjg.v20.i26.8341]
URL: https://www.wjgnet.com/1948-5182/full/v20/i26/8341.htm
Number Citing Articles
1
Tiantian Chen, Xiaohong Zuo, Shengju Wang, Penglong Yu, Jie Yuan, Shujun Wei, Jiayi Chen, Yue Sun, Yongxiang Gao, Xueping Li. The effect of vitamin D supplementation on the progression of fibrosis in patients with chronic liver diseaseMedicine 2020; 99(19): e20296 doi: 10.1097/MD.0000000000020296
2
Mohammad Mohammadi, Roghayeh Abbasalipourkabir, Nasrin Ziamajidi. Fish oil and chicoric acid combination protects better against palmitate-induced lipid accumulation via regulating AMPK-mediated SREBP-1/FAS and PPARα/UCP2 pathwaysArchives of Physiology and Biochemistry 2020; : 1 doi: 10.1080/13813455.2020.1789881
3
Yi Chen, Xueyang Chen, Jianguo Gao, Chengfu Xu, Ping Xu, Youming Li, Yong Zhu, Chaohui Yu. Long noncoding RNA FLRL2 alleviated nonalcoholic fatty liver disease through Arntl‐Sirt1 pathwayThe FASEB Journal 2019; 33(10): 11411 doi: 10.1096/fj.201900643RRR
4
Hong-Jun Chen, Jin Liu. Actein ameliorates hepatic steatosis and fibrosis in high fat diet-induced NAFLD by regulation of insulin and leptin resistantBiomedicine & Pharmacotherapy 2018; 97: 1386 doi: 10.1016/j.biopha.2017.09.093
5
Shu-ting Wang, Jing Zheng, He-wei Peng, Xiao-lin Cai, Xin-ting Pan, Hui-quan Li, Qi-zhu Hong, Xian-E Peng. Physical activity intervention for non-diabetic patients with non-alcoholic fatty liver disease: a meta-analysis of randomized controlled trialsBMC Gastroenterology 2020; 20(1) doi: 10.1186/s12876-020-01204-3
6
Priscila Silva Figueiredo, Aline Carla Inada, Gabriela Marcelino, Carla Maiara Lopes Cardozo, Karine de Cássia Freitas, Rita de Cássia Avellaneda Guimarães, Alinne Pereira de Castro, Valter Aragão do Nascimento, Priscila Aiko Hiane. Fatty Acids Consumption: The Role Metabolic Aspects Involved in Obesity and Its Associated DisordersNutrients 2017; 9(10): 1158 doi: 10.3390/nu9101158
7
Jinghua Wang, Yishu Chen, Ran Pan, Chao Wu, Shenghui Chen, Lan Li, Youming Li, Chaohui Yu, Zhuo‐xian Meng, Chengfu Xu. Leukocyte cell‐derived chemotaxin 2 promotes the development of nonalcoholic fatty liver disease through STAT‐1 pathway in miceLiver International 2021; 41(4): 777 doi: 10.1111/liv.14816
8
Yi Chen, Haixiu Huang, Chengfu Xu, Chaohui Yu, Youming Li. Long Non-Coding RNA Profiling in a Non-Alcoholic Fatty Liver Disease Rodent Model: New Insight into PathogenesisInternational Journal of Molecular Sciences 2017; 18(1): 21 doi: 10.3390/ijms18010021
9
Francesco Baratta, Daniele Pastori, Licia Polimeni, Giulia Tozzi, Francesco Violi, Francesco Angelico, Maria Del Ben. Does Lysosomial Acid Lipase Reduction Play a Role in Adult Non-Alcoholic Fatty Liver Disease?International Journal of Molecular Sciences 2015; 16(12): 28014 doi: 10.3390/ijms161226085
10
Yun Kyung Cho, Yu Mi Kang, Jee Hee Yoo, Jiwoo Lee, Seung Eun Lee, Dong Hyun Yang, Joon-Won Kang, Joong-Yeol Park, Chang Hee Jung, Hong-Kyu Kim, Woo Je Lee. The impact of non-alcoholic fatty liver disease and metabolic syndrome on the progression of coronary artery calcificationScientific Reports 2018; 8(1) doi: 10.1038/s41598-018-30465-y
11
Arianna Pani, Riccardo Giossi, Danilo Menichelli, Veronica Andrea Fittipaldo, Francesca Agnelli, Elvira Inglese, Alessandra Romandini, Rossana Roncato, Basilio Pintaudi, Francesco Del Sole, Francesco Scaglione. Inositol and Non-Alcoholic Fatty Liver Disease: A Systematic Review on Deficiencies and SupplementationNutrients 2020; 12(11): 3379 doi: 10.3390/nu12113379
12
Adriana Corona-Pérez, Mauricio Díaz-Muñoz, Ida Soto Rodríguez, Estela Cuevas, Margarita Martínez-Gómez, Francisco Castelán, Jorge Rodríguez-Antolín, Leticia Nicolás-Toledo. High Sucrose Intake Ameliorates the Accumulation of Hepatic Triacylglycerol Promoted by Restraint Stress in Young RatsLipids 2015; 50(11): 1103 doi: 10.1007/s11745-015-4066-0
13
Xiao-Yan Wang, Xue-Lan Song, Yi Zhang, Gan Luo, Hai-Chuan Tai, Zhao-Heng Lin, Pei-Li Zhu, Nan Sun, Zhu-Sheng Chu, Zhi-Ling Yu, Si-Yuan Pan, Jin-Fa Tang, Kam-Ming Ko, Jenny Wilkinson. Evaluation of Beneficial and Adverse Effects of a Diet Supplemented with Schisandrae Fructus Seed Ethanol Extract on Lipid and Glucose Metabolism in Normal and Hypercholesterolemic/Hyperglycemic MiceEvidence-Based Complementary and Alternative Medicine 2021; 2021: 1 doi: 10.1155/2021/8858962
14
Shengtao Zhu, Jihong Shi, Chunpeng Ji, Guang Yang, Jie Xing, Feng Zhu, Liming Lin, Aijun Xing, Zhe Huang, Chenrui Zhu, Xiaoming Wei, Shutian Zhang, Junchao Gu, Shouling Wu. Association of the ideal cardiovascular behaviors and factors with the incidence of nonalcoholic fatty liver diseaseEuropean Journal of Gastroenterology & Hepatology 2018; 30(5): 578 doi: 10.1097/MEG.0000000000001069
15
Byoung-Joon Song, Mohammed Akbar, Inho Jo, James P. Hardwick, Mohamed A. Abdelmegeed. Cytochrome P450 Function and Pharmacological Roles in Inflammation and CancerAdvances in Pharmacology 2015; 74: 303 doi: 10.1016/bs.apha.2015.04.002
16
Tian Shen, Bilin Xu, Tao Lei, Lin Chen, Cuiping Zhang, Zhenhua Ni. Sitagliptin reduces insulin resistance and improves rat liver steatosis via the SIRT1/AMPKα pathwayExperimental and Therapeutic Medicine 2018;  doi: 10.3892/etm.2018.6554
17
Elisabete Martins, Ana Oliveira. NAFLD and cardiovascular diseasePorto Biomedical Journal 2018; 3(2): e2 doi: 10.1016/j.pbj.0000000000000002
18
Suzanne E. Mahady, Jacob George. Exercise and diet in the management of nonalcoholic fatty liver diseaseMetabolism 2016; 65(8): 1172 doi: 10.1016/j.metabol.2015.10.032
19
Shahla Rezaei, Reza Tabrizi, Peyman Nowrouzi-Sohrabi, Mohammad Jalali, Mojtaba Shabani-Borujeni, Shayan Modaresi, Maryam Gholamalizadeh, Saeid Doaei. The Effects of Vitamin D Supplementation on Anthropometric and Biochemical Indices in Patients With Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-analysisFrontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.732496
20
Eunok Lee, Yeni Lim, Sung Won Kwon, Oran Kwon. Pinitol consumption improves liver health status by reducing oxidative stress and fatty acid accumulation in subjects with non-alcoholic fatty liver disease: A randomized, double-blind, placebo-controlled trialThe Journal of Nutritional Biochemistry 2019; 68: 33 doi: 10.1016/j.jnutbio.2019.03.006
21
Vishal Patel, Amit Joharapurkar, Samadhan Kshirsagar, Maulik Patel, Brijesh Sutariya, Hiren Patel, Dheerendra Pandey, Dipam Patel, Ramchandra Ranvir, Shekhar Kadam, Rajesh Bahekar, Mukul Jain. Coagonist of glucagon-like peptide-1 and glucagon receptors ameliorates nonalcoholic fatty liver diseaseCanadian Journal of Physiology and Pharmacology 2018; 96(6): 587 doi: 10.1139/cjpp-2017-0683
22
Olivier F. Noel, Christopher D. Still, Glenn S. Gerhard. Genetics of Bariatric Surgery OutcomesEndocrinology and Metabolism Clinics of North America 2016; 45(3): 623 doi: 10.1016/j.ecl.2016.04.011
23
Shahida Khan, Ashraf Ali, Sarah Khan, Ahmed Bakillah, Ghazi Damanhouri, Aziz Khan, Ahmed Makki, Ibtehal AlAnsari, Naheed Banu. Current therapies in alleviating liver disorders and cancers with a special focus on the potential of vitamin DNutrition & Metabolism 2018; 15(1) doi: 10.1186/s12986-018-0251-5
24
Francesco Baratta, Daniele Pastori, Domenico Ferro, Giovanna Carluccio, Giulia Tozzi, Francesco Angelico, Francesco Violi, Maria Del Ben. Reduced lysosomal acid lipase activity: A new marker of liver disease severity across the clinical continuum of non-alcoholic fatty liver disease?World Journal of Gastroenterology 2019; 25(30): 4172-4180 doi: 10.3748/wjg.v25.i30.4172
25
Birgit Knebel, Sonja Hartwig, Jutta Haas, Stefan Lehr, Simon Goeddeke, Franciscus Susanto, Lothar Bohne, Sylvia Jacob, Cornelia Koellmer, Ulrike Nitzgen, Dirk Müller-Wieland, Jorg Kotzka. Peroxisomes compensate hepatic lipid overflow in mice with fatty liverBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2015; 1851(7): 965 doi: 10.1016/j.bbalip.2015.03.003
26
Yali Li, Xinmei Chen, Jie Xue, Jiangyun Liu, Xinhua Chen, Muhuyati Wulasihan. Flavonoids furom Coreopsis tinctoria adjust lipid metabolism in hyperlipidemia animals by down-regulating adipose differentiation-related proteinLipids in Health and Disease 2014; 13(1) doi: 10.1186/1476-511X-13-193
27
Madhangi Parameswaran, Hamzah A Hasan, Jafor Sadeque, Sharan Jhaveri, Chaithanya Avanthika, Abimbola E Arisoyin, Maulik B Dhanani, Swaroopa M Rath . Factors That Predict the Progression of Non-alcoholic Fatty Liver Disease (NAFLD)Cureus 2021;  doi: 10.7759/cureus.20776
28
L. Kořínková, V. Pražienková, L. Černá, A. Karnošová, B. Železná, J. Kuneš, Lenka Maletínská. Pathophysiology of NAFLD and NASH in Experimental Models: The Role of Food Intake Regulating PeptidesFrontiers in Endocrinology 2020; 11 doi: 10.3389/fendo.2020.597583
29
Francesco Baratta, Daniele Pastori, Maria Del Ben, Licia Polimeni, Giancarlo Labbadia, Serena Di Santo, Fiorella Piemonte, Giulia Tozzi, Francesco Violi, Francesco Angelico. Reduced Lysosomal Acid Lipase Activity in Adult Patients With Non-alcoholic Fatty Liver DiseaseEBioMedicine 2015; 2(7): 750 doi: 10.1016/j.ebiom.2015.05.018
30
L. Loffredo, F. Baratta, P. Ludovica, S. Battaglia, R. Carnevale, C. Nocella, M. Novo, G. Pannitteri, F. Ceci, F. Angelico, F. Violi, M. Del Ben. Effects of dark chocolate on endothelial function in patients with non-alcoholic steatohepatitisNutrition, Metabolism and Cardiovascular Diseases 2018; 28(2): 143 doi: 10.1016/j.numecd.2017.10.027
31
Schohraya Spahis, Fernando Alvarez, Nejma Ahmed, Josée Dubois, Ramy Jalbout, Massimiliano Paganelli, Kelly Grzywacz, Edgard Delvin, Noel Peretti, Emile Levy. Non-alcoholic fatty liver disease severity and metabolic complications in obese children: impact of omega-3 fatty acidsThe Journal of Nutritional Biochemistry 2018; 58: 28 doi: 10.1016/j.jnutbio.2018.03.025
32
Sonia Mansourian Hosseini, Soodabeh Aliashrafi, Mehrangiz Ebrahimi-Mameghani. The Effect of a Single Intramuscular Injection of Cholecalciferol on the Serum Levels of Vitamin D, Adiponectin, Insulin Resistance, and Liver Function in Women with Non-Alcoholic Fatty Liver Disease (NAFLD): A Randomized, Controlled Clinical TrialIranian Red Crescent Medical Journal 2018; (In Press) doi: 10.5812/ircmj.60746
33
L. Loffredo, M. Del Ben, L. Perri, R. Carnevale, C. Nocella, E. Catasca, F. Baratta, F. Ceci, L. Polimeni, P. Gozzo, F. Violi, F. Angelico. Effects of dark chocolate on NOX-2-generated oxidative stress in patients with non-alcoholic steatohepatitisAlimentary Pharmacology & Therapeutics 2016; 44(3): 279 doi: 10.1111/apt.13687
34
Fariborz Mansour-Ghanaei, Makan Pourmasoumi, Amir Hadi, Nahid Ramezani-Jolfaie, Farahnaz Joukar. The Efficacy of Vitamin D Supplementation against Nonalcoholic Fatty Liver Disease: A Meta-AnalysisJournal of Dietary Supplements 2020; 17(4): 467 doi: 10.1080/19390211.2019.1624671
35
Han-Qiong LUO, Jie SHEN, Cai-Ping CHEN, Xiao MA, Chao LIN, Qiong OUYANG, Chun-Xiao XUAN, Jine LIU, Hong-Bin SUN, Jun LIU. Lipid-lowering effects of oleanolic acid in hyperlipidemic patientsChinese Journal of Natural Medicines 2018; 16(5): 339 doi: 10.1016/S1875-5364(18)30065-7
36
Tomohiro Bito, Eri Okumura, Masaki Fujishima, Fumio Watanabe. Potential of Chlorella as a Dietary Supplement to Promote Human HealthNutrients 2020; 12(9): 2524 doi: 10.3390/nu12092524
37
W. Timothy Garvey, Jeffrey I. Mechanick, Elise M. Brett, Alan J. Garber, Daniel L. Hurley, Ania M. Jastreboff, Karl Nadolsky, Rachel Pessah-Pollack, Raymond Plodkowski. American Association of Clinical Endocrinologists and American College of Endocrinology Comprehensive Clinical Practice Guidelines Formedical Care of Patients with ObesityEndocrine Practice 2016; 22: 1 doi: 10.4158/EP161365.GL
38
Mehrangiz Ebrahimi-Mameghani, Zahra Sadeghi, Mahdieh Abbasalizad Farhangi, Elnaz Vaghef-Mehrabany, Soodabeh Aliashrafi. Glucose homeostasis, insulin resistance and inflammatory biomarkers in patients with non-alcoholic fatty liver disease: Beneficial effects of supplementation with microalgae Chlorella vulgaris : A double-blind placebo-controlled randomized clinical trialClinical Nutrition 2017; 36(4): 1001 doi: 10.1016/j.clnu.2016.07.004
39
Ilaria Barchetta, Maria Del Ben, Francesco Angelico, Michele Di Martino, Antonio Fraioli, Giuseppe La Torre, Rosella Saulle, Ludovica Perri, Sergio Morini, Claudio Tiberti, Laura Bertoccini, Flavia Agata Cimini, Francesca Panimolle, Carlo Catalano, Marco Giorgio Baroni, Maria Gisella Cavallo. No effects of oral vitamin D supplementation on non-alcoholic fatty liver disease in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trialBMC Medicine 2016; 14(1) doi: 10.1186/s12916-016-0638-y
40
Maryam jarhahzadeh, Pezhman Alavinejad, Farnaz Farsi, Durdana Husain, Afshin Rezazadeh. The effect of turmeric on lipid profile, malondialdehyde, liver echogenicity and enzymes among patients with nonalcoholic fatty liver disease: a randomized double blind clinical trialDiabetology & Metabolic Syndrome 2021; 13(1) doi: 10.1186/s13098-021-00731-7
41
Chiara Gelli, Mirko Tarocchi, Ludovico Abenavoli, Laura Di Renzo, Andrea Galli, Antonino De Lorenzo. Effect of a counseling-supported treatment with the Mediterranean diet and physical activity on the severity of the non-alcoholic fatty liver diseaseWorld Journal of Gastroenterology 2017; 23(17): 3150-3162 doi: 10.3748/wjg.v23.i17.3150
42
Meredith A Sigler, Lee Congdon, Krystal L Edwards. An Evidence-Based Review of Statin Use in Patients With Nonalcoholic Fatty Liver DiseaseClinical Medicine Insights: Gastroenterology 2018; 11: 117955221878750 doi: 10.1177/1179552218787502
43
Maria Del Ben, Licia Polimeni, Francesco Baratta, Daniele Pastori, Francesco Angelico. The role of nutraceuticals for the treatment of non-alcoholic fatty liver diseaseBritish Journal of Clinical Pharmacology 2017; 83(1): 88 doi: 10.1111/bcp.12899
44
Polyana C. Marinho, Aline B. Vieira, Priscila G. Pereira, Kíssila Rabelo, Bianca T. Ciambarella, Ana L. R. Nascimento, Erika Cortez, Aníbal S. Moura, Fernanda V. Guimarães, Marco A. Martins, Gonzalo Barquero, Rodrigo N. Ferreira, Jorge J. de Carvalho. Capybara Oil Improves Hepatic Mitochondrial Dysfunction, Steatosis, and Inflammation in a Murine Model of Nonalcoholic Fatty Liver DiseaseEvidence-Based Complementary and Alternative Medicine 2018; 2018: 1 doi: 10.1155/2018/4956079
45
Xingtong Shen, Huaiyuan Guo, Jinjin Xu, Jinliang Wang. Inhibition of lncRNA HULC improves hepatic fibrosis and hepatocyte apoptosis by inhibiting the MAPK signaling pathway in rats with nonalcoholic fatty liver diseaseJournal of Cellular Physiology 2019; 234(10): 18169 doi: 10.1002/jcp.28450